Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q1 2020 · 10-Q
Revenue$21.55M$21.55M+18.5% vs Q1 2019 Net Income-$418.00K-$418.00KN/M vs Q1 2019 EPS Diluted-$0.02-$0.02N/M vs Q1 2019 Gross Profit$12,663,000+22.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flow$557,000−56.1% Free Cash Flowderived$28,000N/M Margins · derivedGross margin58.8%+1.9 pt vs Q1 2019
Operating margin0.2%+2.5 pt vs Q1 2019
Net margin-1.9%+3.3 pt vs Q1 2019
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end